Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications.

IF 4.9 2区医学 Q1 CHEMISTRY, MEDICINAL

Marine Drugs Pub Date : 2025-01-28 DOI:10.3390/md23020060

Joana Carrasqueira, Susana Bernardino, Raul Bernardino, Clélia Afonso

{"title":"Marine-Derived Polysaccharides and Their Potential Health Benefits in Nutraceutical Applications.","authors":"Joana Carrasqueira, Susana Bernardino, Raul Bernardino, Clélia Afonso","doi":"10.3390/md23020060","DOIUrl":null,"url":null,"abstract":"<p><p>Marine-derived polysaccharides have sparked immense interest in the nutraceutical industry as they possess a wide range of bioactivities which are highlighted in this review. These include antioxidants, anti-inflammatory, anti-cancer, gut microbiota regulator, anti-diabetic, and anti-obesity. Algae, marine invertebrates, vertebrates, and microorganisms are the main sources of marine polysaccharides, such as alginate, fucoidan, laminarin, carrageenan, chitosan, glycosaminoglycans, and exopolysaccharides. The structure and functional groups of these compounds influence their bioactive properties. Moreover, the functional properties of polysaccharides, such as gelling, thickening, and stabilising capabilities, are also crucial in product development, where they can serve as gluten substitutes in bakery goods and stabilisers in icings, sauces, and yoghurts. The potential of commercial products under development, such as marine polysaccharide supplements, is discussed, along with already commercialised products in the nutraceutical market. This review emphasises the enormous potential of marine-derived polysaccharides as bioactive compounds with health benefits and commercial value.</p>","PeriodicalId":18222,"journal":{"name":"Marine Drugs","volume":"23 2","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11857343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marine Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/md23020060","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

Marine-derived polysaccharides have sparked immense interest in the nutraceutical industry as they possess a wide range of bioactivities which are highlighted in this review. These include antioxidants, anti-inflammatory, anti-cancer, gut microbiota regulator, anti-diabetic, and anti-obesity. Algae, marine invertebrates, vertebrates, and microorganisms are the main sources of marine polysaccharides, such as alginate, fucoidan, laminarin, carrageenan, chitosan, glycosaminoglycans, and exopolysaccharides. The structure and functional groups of these compounds influence their bioactive properties. Moreover, the functional properties of polysaccharides, such as gelling, thickening, and stabilising capabilities, are also crucial in product development, where they can serve as gluten substitutes in bakery goods and stabilisers in icings, sauces, and yoghurts. The potential of commercial products under development, such as marine polysaccharide supplements, is discussed, along with already commercialised products in the nutraceutical market. This review emphasises the enormous potential of marine-derived polysaccharides as bioactive compounds with health benefits and commercial value.

查看原文本刊更多论文

海洋来源的多糖及其在营养保健方面的潜在益处。

海洋来源的多糖因其具有广泛的生物活性而引起了营养保健行业的极大兴趣，本文将重点介绍这些生物活性。这些包括抗氧化剂，抗炎，抗癌，肠道微生物调节，抗糖尿病和抗肥胖。藻类、海洋无脊椎动物、脊椎动物和微生物是海洋多糖的主要来源，如海藻酸盐、岩藻聚糖、层粘胶蛋白、卡拉胶、壳聚糖、糖胺聚糖和胞外多糖。这些化合物的结构和官能团影响它们的生物活性。此外，多糖的功能特性，如胶凝、增稠和稳定能力，在产品开发中也至关重要，它们可以在烘焙食品中作为面筋替代品，在糖霜、酱汁和酸奶中作为稳定剂。讨论了正在开发的商业产品的潜力，例如海洋多糖补充剂，以及营养保健品市场上已经商业化的产品。这篇综述强调了海洋多糖作为具有健康益处和商业价值的生物活性化合物的巨大潜力。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Marine Drugs 医学-医药化学

CiteScore

9.60

自引率

14.80%

发文量

671

审稿时长

1 months

期刊介绍： Marine Drugs (ISSN 1660-3397) publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.